NCT05129865View on ClinicalTrials.gov

LYT-300 in Healthy Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

October 18, 2023

Study Completion Date

October 23, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

LYT-300

A prodrug of allopregnanolone, a small molecule drug

OTHER

Placebo

Placebo for LYT-300

Trial Locations (1)

5000

CMAX, Adelaide

All Listed Sponsors
collaborator

Novotech (Australia) Pty Limited

INDUSTRY

lead

PureTech

INDUSTRY

NCT05129865 - LYT-300 in Healthy Volunteers | Biotech Hunter | Biotech Hunter